Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Half Yearly Results - Fresenius Kabi Oncology

Fresenius Kabi Oncology

BSE: 532545|NSE: FKONCO|ISIN: INE575G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Fresenius Kabi Oncology is not traded in the last 30 days
Fresenius Kabi Oncology is not traded in the last 30 days
Download Annual Report PDF Format 2013 | 2012 | 2011 | 2010

Half Yearly Results of Fresenius Kabi Oncology

------------------- in Rs. Cr. -------------------
Sep '13 Mar '13 Sep '12 Mar '12 Sep '11
Net Sales/Income from operations 162.51 220.92 275.32 215.38 255.73
Other Operating Income 60.50 77.35 22.70 34.73 18.47
Total Income From Operations 223.01 298.28 298.02 250.11 274.20
EXPENDITURE
Consumption of Raw Materials 70.63 80.59 111.14 105.66 100.40
Purchase of Traded Goods 2.19 2.99 1.25 1.89 0.96
Increase/Decrease in Stocks -6.52 -15.69 -15.33 -6.37 12.39
Power & Fuel -- -- -- -- --
Employees Cost 35.59 34.56 35.76 32.13 28.85
Depreciation 14.44 13.22 12.56 12.31 11.66
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses 50.04 57.21 37.82 31.61 12.18
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 91.48 65.95 57.04 57.69 77.74
P/L Before Other Inc. , Int., Excpt. Items & Tax -34.84 59.44 57.78 15.19 30.03
Other Income 0.86 0.82 0.98 0.54 0.85
P/L Before Int., Excpt. Items & Tax -33.99 60.26 58.76 15.73 30.88
Interest 2.64 -9.79 7.19 7.50 7.31
P/L Before Exceptional Items & Tax -36.62 70.05 51.57 8.23 23.56
Exceptional Items -- -- -- -- --
P/L Before Tax -36.62 70.05 51.57 8.23 23.56
Tax 3.37 22.64 11.58 4.70 5.47
P/L After Tax from Ordinary Activities -39.99 47.40 39.99 3.53 18.09
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -6.81 -- 2.75 37.21
Net Profit/(Loss) For the Period -39.99 40.60 39.99 6.28 55.31
Equity Share Capital 15.82 15.82 15.82 15.82 15.82
Reserves Excluding Revaluation Reserves 617.36 -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -2.53 -- 2.53 -- 1.14
Diluted EPS -2.53 -- 2.53 -- 1.14
EPS After Extra Ordinary
Basic EPS -2.53 -- 2.53 -- 3.50
Diluted EPS -2.53 -- 2.53 -- 3.50
Public Share Holding
No Of Shares (Crores) 3.01 3.01 1.58 1.58 1.58
Share Holding (%) 19.00 19.00 10.00 10.00 10.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 12.82 1.28 14.24 14.24 14.24
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 81.00 81.00 90.00 90.00 90.00
Notes
Source : Dion Global Solutions Limited

Results of Fresenius Kabi

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for freseniuskabioncology
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.